Bac2a [L2R][A3W][A11R]

General Information


DRACP ID  DRACP00474

Peptide Name   Bac2a [L2R][A3W][A11R]

Sequence  RRWRIVVIRVRR

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>50 µM Resazurin assay 2h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis>50 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00474

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C74H133N31O13

Absent amino acids  ACDEFGHKLMNPQSTY

Common amino acids  R

Mass  186144

Pl  13.2

Basic residues  6

Acidic residues  0

Hydrophobic residues  6

Net charge  6

Boman Index  -6523

Hydrophobicity  -52.5

Aliphatic Index  137.5

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  500

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24038773

Title  The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability

Doi 10.1002/cbic.201300274

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.